Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Ouwens

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Research Synthesis Methods|November 1, 2020
Alternative weighting schemes when performing matching-adjusted indirect comparisonsDan Jackson, Kirsty Rhodes, Mario Ouwens
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 3, 2018
A Validation Study of the Rank-Preserving Structural Failure Time Model: Confidence Intervals and Unique, Multiple, and Erroneous SolutionsMario Ouwens, Ole Hauch, Stefan Franzén
Journal of Comparative Effectiveness Research|December 15, 2023
Improved estimation of overall survival and progression-free survival for state transition modelingPeter C Wigfield, Bart Heeg, Mario Ouwens
Clinical Therapeutics|March 5, 2013
Economic evaluation of fulvestrant 500 mg versus generic nonsteroidal aromatase inhibitors in patients with advanced breast cancer in the United KingdomRomita Das, Shannon Cope, Mario Ouwens, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 9, 2013
Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference valuesWilliam Dunlop, Itrat Iqbal, Ifty Khan, et al.
Pharmacoeconomics|March 29, 2025
Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic AreasBart Heeg, Dawn Lee, Jane Adam, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 13, 2019
Extrapolating Survival Data Using Historical Trial-Based a Priori DistributionsFanni Soikkeli, Mahmoud Hashim, Mario Ouwens, et al.
BMC Medical Research Methodology|May 25, 2022
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS studyKirsty Rhodes, Martin Jenkins, Enrico de Nigris, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 19, 2010
Cost-effectiveness study comparing pharmaceutically licensed plasma for transfusion (OctaplasLG®) versus fresh frozen plasma (FFP) in critically Ill patients in the UKMargreet C van Eerd, J N Mario Ouwens, Maria A de Peuter
Annals of Epidemiology|November 19, 2021
Evaluating a Cox marginal structural model to assess the comparative effectiveness of inhaled corticosteroids versus no inhaled corticosteroid treatment in chronic obstructive pulmonary diseaseClaudia Cabrera, Céline Quélen, Mario Ouwens, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Research Synthesis Methods|November 1, 2020
Alternative weighting schemes when performing matching-adjusted indirect comparisonsDan Jackson, Kirsty Rhodes, Mario Ouwens
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 3, 2018
A Validation Study of the Rank-Preserving Structural Failure Time Model: Confidence Intervals and Unique, Multiple, and Erroneous SolutionsMario Ouwens, Ole Hauch, Stefan Franzén
Journal of Comparative Effectiveness Research|December 15, 2023
Improved estimation of overall survival and progression-free survival for state transition modelingPeter C Wigfield, Bart Heeg, Mario Ouwens
Clinical Therapeutics|March 5, 2013
Economic evaluation of fulvestrant 500 mg versus generic nonsteroidal aromatase inhibitors in patients with advanced breast cancer in the United KingdomRomita Das, Shannon Cope, Mario Ouwens, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 9, 2013
Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference valuesWilliam Dunlop, Itrat Iqbal, Ifty Khan, et al.
Pharmacoeconomics|March 29, 2025
Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic AreasBart Heeg, Dawn Lee, Jane Adam, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 13, 2019
Extrapolating Survival Data Using Historical Trial-Based a Priori DistributionsFanni Soikkeli, Mahmoud Hashim, Mario Ouwens, et al.
BMC Medical Research Methodology|May 25, 2022
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS studyKirsty Rhodes, Martin Jenkins, Enrico de Nigris, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 19, 2010
Cost-effectiveness study comparing pharmaceutically licensed plasma for transfusion (OctaplasLG®) versus fresh frozen plasma (FFP) in critically Ill patients in the UKMargreet C van Eerd, J N Mario Ouwens, Maria A de Peuter
Annals of Epidemiology|November 19, 2021
Evaluating a Cox marginal structural model to assess the comparative effectiveness of inhaled corticosteroids versus no inhaled corticosteroid treatment in chronic obstructive pulmonary diseaseClaudia Cabrera, Céline Quélen, Mario Ouwens, et al.
Pageof 5